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Despite the increased prevalence of obesity and associated diseases among pediatric 
minorities, the intensity-specific effects of aerobic training have not been examined 
extensively in adolescent minorities. Fifteen morbidly obese, sedentary and insulin-
resistant Black and Latino adolescents completed two-months of low-volume/moderate-
intensity aerobic exercise training to examine the effects of training on three phenotypes 
dysregulated in obese and physically inactive states: insulin sensitivity (SI); fibrinolytic 
potential, as indicated by plasminogen activator inhibitor type 1 (PAI-1) and tissue 
plasminogen activator (t-PA) antigen levels; and chronic low-grade systemic inflammation, 
as indicated by C-reactive protein (CRP). In response to training, SI increased ~37% (1.00 






, p<0.05) and t-PA antigen levels increased ~15% (6.34 ± 
0.51 to 7.32 ± 0.85 ng/mL, p<0.05). No significant changes in CRP or PAI-1 antigen were 
observed. Our findings demonstrate that aerobic training improves insulin sensitivity and 
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Habitual levels of moderate physical activity decrease the risk of all-cause mortality 
and cardiovascular disease (CVD) over the lifespan (van Dam et al., 2009; Barengo et al., 
2004; Blair et al., 1989). Despite public knowledge of the benefits of physical activity, 
Americans are becoming increasingly inactive as nearly half of all Americans do not meet 
minimal physical activity recommendations (CDC DNPAO a & b, 2008; CDC, 2003). 
Some of the most pronounced declines in physical activity are observed in the transition 
from childhood to adolescence (Nader et al., 2008). Adolescent-onset physical inactivity is 
especially prevalent in minority populations, where national physical inactivity rates are as 
high as 42% among Black adolescent females (AHA II, 2009; Kimm et al., 2002). Physical 
inactivity in youth is associated with an increased risk of obesity (Dwyer et al., 2009; 
Ogden et al., 2006; Raitakari et al., 1994). 
The obesity-associated ‗metabolic syndrome‘ phenotype presents as a clustering of 
metabolic disturbances including: insulin resistance, hypertension, dyslipidemia, low-grade 
systemic inflammation, endothelial dysfunction, enhanced thrombosis, and impaired 
fibrinolysis (Cirillo et al., 2009; Steinberger et al., 2009; Shaibi et al., 2008; ACE, 2003; 
Sakkinen et al., 2000; Bouchard, 1997). The clustering of these cardiometabolic risk factors 
was classically termed ‗the insulin resistance syndrome‘ as insulin insensitivity was 
thought to be the central pathological moderator (Shaibi et al., 2008; Narayan, 2006). 
Recent studies, however, suggest the combination of insulin resistance and obesity-
associated chronic low-grade systemic inflammation result in the clustering of these 
metabolic syndrome components and the subsequently increased risk of type 2 diabetes and 





Correlations between body mass index and metabolic syndrome phenotypes may be 
attributable to the disruptive endocrine and paracrine effects of excessive adiposity on 
multi-organ cell signaling mechanisms (Weiss, Taksali & Caprio, 2006; Weiss et al., 2004). 
Excessive adiposity results in the elevated secretion of a variety of pro-inflammatory 
cytokines and proteins, termed ‗adipokines,‘ and increases circulating levels of free fatty 
acids through enhanced rates of lipolysis. An increased number of free fatty acids in the 
circulation can induce hepatic and peripheral insulin resistance (Ragheb et al., 2009). 
Elevated adipokine circulation is thought to contribute to the low-grade systemic 
inflammation observed in obese states and to dysregulate a variety of systemic signaling 
pathways (Antuna-Puente et al., 2008). The downstream effects of  enhanced adipokine 
secretion include the disruption of peripheral and hepatic insulin signaling, blood 
hemostasis and angiogenic repair mechanisms, all of which may result in the presentation 
of metabolic syndrome phenotypes such as insulin insensitivity, diminished fibrinolysis and 
endothelial dysfunction (Galic, Oakhill & Steinberg, 2010; You et al., 2008).   
Skeletal muscle may also behave in an endocrine-, paracrine-, and autocrine-like 
fashion through the release of a variety of cytokines, termed ‗myokines,‘ which may exert 
anti-inflammatory, angiogenic and insulin-sensitizing effects (Mathur & Pedersen, 2008). 
Exercise training may attenuate metabolic syndrome components through enhanced 
myokine secretion and subsequent myokine-induced cross-talk between the skeletal muscle 
and the adipose, hepatic and vasculature tissues (Pedersen, 2009; Mathur & Pedersen, 




components is of interest as attenuation of such phenotypes suggests a transition towards a 
more metabolically favorable systemic phenotype (Pedersen, 2009).  
Two well-established interventions used to attenuate metabolic syndrome 
components are dietary interventions, which primarily target the adipose and gastric 
systems, and exercise training, which primarily targets the skeletal muscle and adipose 
tissues. As such, aerobic exercise training may induce a transition towards a more 
metabolically favorable systemic phenotype such that it attenuates peripheral and hepatic 
insulin sensitivity, reduces systemic inflammation, decreases free fatty acid levels and 
increases fibrinolysis. Together, these positive training adaptations may reduce the risk of 
type 2 diabetes, CVD and associated mortality by improving insulin sensitivity and 
reducing pro-atherosclerotic stimuli (Ginsberg & MacCallum, 2009; AACE 2002; 
Berenson et al., 1998).  
Large-scale longitudinal studies demonstrate that atherosclerotic processes begin in 
youth and increase in proportion to the number of metabolic syndrome components 
(Zieske, Malcom & Strong, 2002). This is particularly alarming as the relative risk of CVD 
is nearly doubled among individuals with metabolic syndrome which has been estimated to 
present in up to 50% of overweight and obese adolescents (ADA, 2008; Galassi, Reynolds 
& He, 2006; Weiss et al., 2004). Previously-conducted exercise intervention studies 
demonstrate favorable changes in metabolic syndrome phenotypes in youth populations, 
despite minor changes in body mass and composition (van der Heijden et al., 2009; 
Conwell et al., 2008; Balagopal et al., 2008; Kim et al. 2007; Bell et al., 2007; Nassis et al., 
2005). However, the majority of these studies are limited to lifestyle-based rather than 




adults from minority populations are at high risk, and there is a lack of literature on the 
effects aerobic exercise training in these populations. We thus felt it was of interest to 
examine the effects of aerobic exercise training on metabolic syndrome components in 





Hypothesis and Specific Aims: 
Hypothesis:  Low-volume/moderate-intensity aerobic exercise training will attenuate 
metabolic syndrome components in previously-sedentary, obese and insulin-resistant 
minority adolescents. 
 
Specific Aim 1: Determine the effects of two-months of low-volume/moderate-intensity 
aerobic training on insulin sensitivity in previously-sedentary and obese adolescent 
minorities. 
Aim 1A: Quantify baseline and final glucose and insulin levels from frequently 
sampled intravenous glucose tolerance testing (FSIVGTT).  
Aim 1B: Examine changes in insulin sensitivity index (SI) in response to training as 
determined by MINMOD Millennium pharmacokinetic modeling software. 
Expected findings include significant improvements in SI in response to two-months of low-
volume/moderate-intensity aerobic exercise training.  
 
Specific Aim 2: Determine the effects of two-months of low-volume/moderate-intensity 
aerobic exercise training on ‗non-traditional‘ metabolic syndrome components.  
Aim 2A: Determine the effects of training on fibrinolytic potential as determined 
by PAI-1 and t-PA antigen levels. 
Aim 2B: Determine the effects of training on low-grade systemic inflammation as 
determined by C-reactive protein (CRP) levels. 
Expected findings include significant decrements in PAI-1 antigen and CRP, and 




Chapter 1: Literature Review 
1.1 Background and Significance 
Washington DC youth demonstrate some of the highest rates of overweight and 
obesity in the United States (Trust for America‘s Health, 2009). Among a multitude of 
purported causes, the high proportion of minority populations (Black and Latino) and an 
obesogenic ‗built‘ environment contribute significantly to the current childhood obesity 
epidemic in Washington DC (Patrick & Nicklas, 2005). Physical activity declines in the 
transition from childhood to adolescence are thought to significantly contribute to the 
current pediatric obesity epidemic (Nader et al., 2008). Although regular physical activity 
has been suggested to attenuate obesity and type 2 diabetes risk in adult populations, the 
magnitude of the intensity-specific effects of aerobic exercise training-induced 
improvements on type 2 diabetes risk factors has been studied very little in pediatric 
populations and even less in pediatric minorities. 
Findings from previously-conducted pediatric studies demonstrate improvements in 
metabolic syndrome phenotypes in response to exercise training and lifestyle-based 
interventions, despite minor changes in body mass and composition; these findings suggest 
the ability of aerobically-trained muscle to attenuate metabolic syndrome components in 
obese and physically inactive states (van der Heijden et al., 2009; Conwell et al., 2008; 
Balagopal et al., 2005; Bell et al., 2007; Nassis et al., 2005). However, further investigation 
of the intensity-specific effects of aerobic exercise training is warranted as many of these 
previously-conducted studies comprise lifestyle-based rather than intensity-specific 
interventions in predominantly White populations. As such, the American Heart 




recommendations for the treatment of pediatric obesity, as no such exercise treatment 
guidelines exist specifically for the management of obesity in youth populations (Daniels et 
al., 2009).  
Examining the effects of aerobic training independent of dietary-induced weight 
loss is of interest as improvements suggest the ability of aerobically-trained muscle to 
mitigate adiposity-associated metabolic aberrations. It is notable that most metabolic 
syndrome or obesity markers are age-related, and show co-morbidity with many age-
related conditions. Thus, in adults, it is very difficult to determine cause-effect relationships 
between inflammation, obesity, physical activity, and lipid profiles when all of them are 
strongly correlated (Donges, Duffield & Drinkwater, 2010; Stowe et al., 2010; Kim et al., 
2007; Oberbach et al., 2006; Short et al., 2003). Moving interventions to younger 
populations has the advantage of decreasing potentially confounding age-related co-morbid 
conditions, to include insulin sensitivity, fibrinolysis and chronic low grade systemic 
inflammation all of which show age-related impairments (Cevenini et al., 2010; Menzel & 
Hilberg, 2009; Ribeiro et al., 2007; Short et al., 2003; Kelly et al., 2004). 
1.2.1 Insulin Resistance 
Insulin resistance in youth is associated with obesity indices and has a largely 
pubertal and post-pubertal onset (Matyka, 2008; Brandou, Brun & Mercier, 2005; Weiss et 
al., 2004). Insulin resistance plays a major role in the development of type 2 diabetes 
(Bergman, 2007; Shulman, 2000). Insulin resistance is characterized by increased insulin 
secretion, peripheral and hepatic insulin insensitivity, and glucose intolerance (Bergman, 
2007; Bergman et al., 1979). Prolonged insulin resistance commonly results in further 




type 2 diabetes (Weiss & Gillis, 2008; Elder et al., 2006). Insulin resistance also 
contributes to the etiology of atherosclerosis and CVD (Zieske, Malcom & Strong, 2003; 
ACE, 2003).  
Insulin resistance is commonly assessed through ‗surrogate determinants‘ of insulin 
sensitivity which include total glucose and insulin area under the curve (AUC) by oral 
glucose tolerance testing (OGTT), homeostasis model assessment for insulin resistance 
(HOMA-IR) and fasting plasma insulin levels. These methods are of limited utility as they 
do not experimentally control for individual variations in glucose and insulin dynamics 
(Bergman, 2007; Yeni-Komshian et al., 2000). Experimental determination of insulin 
sensitivity can be quantified by frequently sampled intravenous glucose tolerance testing 
(FSIVGTT) or hyperinsulinemic-euglycemic clamp. FSIVGTT enables calculation of 
insulin-stimulated glucose uptake, or insulin sensitivity index (SI) through pharmacokinetic 
modeling of plasma insulin and glucose levels following exogenous glucose and insulin 
administration. Use of mathematical modeling software enables determination of steady-
state insulin-dependent glucose uptake, or SI, by FSIVGTT through quantification of a 
series of pre-programmed peripheral and hepatic glucose and insulin rate constants 
(Bergman, 2007; Bergman, Beard & Chen, 1986).  
1.2.2 Exercise Training and Insulin Resistance  
Previously-conducted exercise intervention studies have demonstrated 
improvements in insulin sensitivity in pediatric populations (Reviewed in Table 1) (van der 
Heijden et al., 2009; Conwell et al., 2008; Bell et al., 2007; Kim et al., 2007; Nassis et al., 





Table 1: Summary of training-induced changes on insulin sensitivity parameters in previously-
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(years ± 






















M; 8 F 
15.6 ± 
0.4  
Aerobic (2 of 4 
sessions  home-
based) 12 




33.2 ± 0.9 to 
33.0 ± 0.8  
DEXA: 
38.4 ± 1.5 
to 37.3 ± 
1.5%* 
SLFSIVGTT: 











walking program 10 n/a n/a 
34.5 ± 1.3 to 
34.9 ± 1.5  n/a 
FSIVGTT: 
32.90% 





M; 6 F 
12.7 ± 
2.32  Circuit training 8 










31.58 ± 4.36 

















per 30 sec 
rest) x 5 
d/wk n/a 
29.6 ± 0.6 to 




31.5 ± 1.0 







21 Greek/ F 
13.1 ± 
1.75  Game-based 12 
40 min x 3 
d/wk 
HR: ~161  
± 2 bpm 
26.8 ± 3.9 to 
26.7 ± 3.8  
DEXA: 
41.4 ± 4.8 




insulin AUC*                                          
Balagopa
l et al., 
2005 
8 







45 min x 3 
d/wk n/a 
38.1 ± 2.1 to 
37.5 ± 2.1  
DEXA: 
45.5 ± 2.3 










White,       
Asian/ M; 
F 9.5 ± 1.0 
Aerobic training 
(20 min) and 
game-based (20 
min) 16 
40 min x 4 
d/wk 
Average 
HR: ~157 ± 
7 bpm n/a 
DEXA: 
44.3 ± 0.3 




















42.8 ± 2.3 




± 6.62 to 41.23 
± 7.10 µU/mL 
 




Nassis et al. demonstrated body mass-independent improvements in insulin sensitivity as 
defined by a ~23.3% decrease in total insulin area under the curve (AUC) in obese girls 
(age 9-15 years) in response to a 12-week game-based aerobic intervention (2005). 




minute warm-up, 25 minutes of ‗physical training‘ games, and a 5-minute cool-down 
(Nassis et al., 2005).  
Conwell et al. demonstrated body mass-independent improvements in SI by 
FSIVGTT in obese youth (BMI 34.5 ± 1.3kg/m
2
, age 8-18 years) after a 10-week home-
based physical activity program which consisted of health education encouraging an 
increased number of steps per day (2008). Bell et al. demonstrated a ~22% increase in 
insulin sensitivity as determined by the amount of glucose required to maintain euglycemia 
(milligrams of glucose infused per kilogram lean body mass per minute), or M(lbm), by 
euglycemic clamp in obese youth (age 9-16 years) in response to eight weeks of circuit 
training (2007). The training regimen consisted of 1 hour sessions administered 3 times 
weekly, which included: 1) a 10 minute warm-up; 2) 40 minutes of alternating one-minute 
intervals of cycling ergometry (~85% maximal heart rate (HRmax) weeks 3-8) and 
resistance training; and 3) a 10 minute cool-down period (Bell et al., 2007). Due to the 
circuit training modality of the Bell et al. study, the individual effects of aerobic and 
resistance training cannot be distinguished.  
Gutin et al. did not observe significant changes in fasting insulin in 12 obese Black 
girls (age 7-11 years) in response to 5 weekly 30 minute sessions of mixed-modality 
(aerobic and resistance) training administered over a 10 week period despite a ~1.4% 
reduction in total body fat as determined by DEXA (1996). In this study, subjects were 
encouraged to maintain their heart rate at >70% HRmax for the 30-minute training session 
which consisted of mixed-modality aerobic and resistance exercise training (cycle 
ergometry, walking/jogging, circuit training, etc.); HR was monitored during 2 of 5 weekly 




fasting insulin in 70 obese children (age 7-11 years, percent total body fat 27-61%) in 
response to four months of aerobic training (1999 I). Subjects engaged in aerobic and 
game-based activities for ~40 min (20 min of aerobic and 20 min game-based exercise) 
four-times per week; average heart during such activities was recorded by use of a heart 
rate monitor, thus exercise intensity was not standardized. All of the aforementioned 
studies are, however, limited by the inclusion of children at different stages of pubertal 
development; insulin sensitivity decreases upon the onset of puberty and displays 
heterogeneous age-related changes between genders (Casazza et al., 2009; Kelly et al., 
2007; Goran & Gower, 2001). 
The following studies did stratify for developmental stages. Balagopal et al. 
enrolled obese subjects, average BMI 38.1 ± 2.1 kg/m
2
, with a Tanner growth stage of 4, 
into a 12-week combined physical activity and dietary intervention program and observed 
an improvement in insulin sensitivity as defined as a ~24% decrease in HOMA-IR (2005). 
The training intensity of this study was not specified; subjects were encouraged to 
participate in aerobic activities, such as brisk walking, 3 times weekly for 45 minutes, and 
one of the weekly exercise sessions was monitored.  
Kim et al., found a ~33.6% decrease in HOMA-IR in 14 obese (BMI 29.5 ± 2.2 
kg/m
2
) Korean adolescent males (age 17 ± 0.11 years) in response to a 6 week jump-rope-
interval training program (2007). This training program consisted of six weeks of 30 
minute training sessions administered five days per week. The training sessions consisted 
of alternating jump rope and one-minute resting intervals; the duration spent exercising 
(jumping rope) was increased from 1 to 4 minutes over the six-week training period (Kim 




A recent study by van der Heijden et al. enrolled 15 post-pubertal (Tanner growth 
stage >4), obese (BMI 33.2 ± 0.9 kg/m
2
), Latino adolescents (age 15.6 ± 0.3 years) into a 
12-week (30 min x 4 days/week) high-intensity (~85% VO2 Peak) aerobic exercise training 
program (2009). In response to this program, subjects demonstrated a 59 ± 19% 
improvement in peripheral insulin sensitivity as determined by stable isotope labeled 
FSIVGTT (SLFSIVGTT), despite no significant changes in body mass and a slight (1.1%) 
decrease in total body fat as determined by DEXA (2009). This study is, however, limited 
in that two of four of the training sessions were home-based.  
Investigation of the insulin-sensitizing effects of low-volume/moderate intensity 
aerobic training is warranted as high-intensity training programs may not be feasible in 
previously-sedentary obese youth populations (Daniels et al., 2009). Houmard et al. suggest 
that low-volume/moderate-intensity and high-volume/high-intensity aerobic training result 
in similar improvements in insulin sensitivity in overweight/obese adults (2004). 
Investigation of the effects of low-volume/moderate-intensity aerobic training on insulin 
sensitivity is thus warranted.  
The aforementioned studies (Balagopal et al., Nassis et al., Kim et al., Ferguson et al., and 
Gutin et al.) are limited by the use of surrogate determinants of insulin sensitivity. All of 
the aforementioned studies are limited in that the training protocols were comprised of 
mixed-modality (discontinuous and intensity-aspecific aerobic and/or resistance exercise 
training) or home-based training sessions. Data from these previous studies present a need 
for interventions controlling for training intensity and utilizing direct methods of insulin 
sensitivity quantification, such as SI by FSIVGTT, as surrogate methods have limited 




prevalence of physical inactivity, obesity and associated metabolic syndrome phenotypes in 
minority groups, investigation of the effects of intensity-controlled aerobic exercise 
training in pediatric minorities is warranted.  
1.3.1 Hypofibrinolysis 
Hemostatic disturbances, characterized by enhanced thrombosis and diminished 
fibrinolysis, comprise another metabolic syndrome phenotype. These disturbances in 
normal blood clotting mechanisms result in elevated blood coagulability and fibrin clot 
development (El-Sayed, El-Sayed & Ahmadizad, 2004). Obesity, insulin resistance and 
physical inactivity exaggerate these disturbances which ultimately contribute to 
atherosclerosis development and progression, and enhanced CVD risk (Wang, 2006; 
Zieske, Malcom & Strong, 2002). 
Fibrinolysis, or the degradation of fibrin clots, primarily occurs through lysis by 
plasmin. The zymogen of plasmin, plasminogen, is activated by tissue and urinary-type 
plasminogen activators, t-PA and u-PA, respectively. Once activated, plasmin serves to 
proteolyze fibrin, leading to fibrin clot degradation (Kohler & Grant, 2000). Plasminogen 
activator inhibitor type 1 (PAI-1) is the primary inhibitor of t-PA and u-PA and thus 
increased PAI-1 to t-PA antigen levels are associated with diminished fibrinolytic activity 
(Kohler & Grant, 2000). PAI-1 and t-PA levels correlate with body mass, adiposity and 
physical activity levels in adolescent and adult populations (Balagopal et al., 2008; 
Kulaputana et al., 2005). 
Elevated PAI-1 protein levels are thought to significantly contribute to the 
hypofibrinolysis observed in insulin resistant states as hyperinsulemia and hyperglycemia 




adipose tissue-derived cytokines and proteins upregulate PAI-1expression and protein 
levels in vivo, including CRP (Jag, Zavadil & Stanley, 2009; Nassis et al., 2005; Kelly et 
al., 2004). The exact signaling mechanisms linking CRP and other metabolic syndrome 
components to hypofibrinolysis are not well characterized.  
1.3.2 Exercise Training and Fibrinolysis 
Previously-conducted aerobic exercise training studies demonstrate favorable 
changes in t-PA and PAI-1 mRNA and protein expression in the skeletal muscle in 
response to aerobic training (Hittel, Kraus & Hoffman, 2004). This suggests that 
aerobically-trained muscle may attenuate the fibrinolytic impairments observed in obese 
and physically inactive states. However, the effects of aerobic training on fibrinolysis in 
obese youth have been infrequently investigated and are limited to lifestyle-based 
interventions, often examining the combined effects of dietary modifications and exercise 
training (Balagopal et al., 2008; Conwell et al., 2008; Ferguson et al., 1999 II).  
In obese pediatric lifestyle intervention groups Balagopal et al. observed no 
significant changes in PAI-1 and t-PA antigen levels, or the molar ratio of PAI-1 to t-PA in 
obese (BMI-for-age percentile 98.5 ± 0.9) adolescents (age 15-18 years) in response to a 
12-week lifestyle and dietary intervention, which consisted of one supervised session per 3 
weekly 45 minute training sessions (2008). Conwell et al. also found no significant changes 
in PAI-1 antigen levels following a 10-week home-based walking program in obese youth 
(BMI 34.5 ± 1.3kg/m
2
, age 8-18 years) (2008). Ferguson et al. did not observe changes in 
PAI-1 antigen levels in obese (BMI 26.8 ± 4.9 kg/m
2
) children (age 9.5 ± 1.0 years) in 
response to 4 months of aerobic and game-based training administered for 40 minutes for 




above 150 bpm while playing aerobic exercise-based games (20 minutes per session) and 
using aerobic exercise equipment (20 minutes per session). Despite no significant changes 
in PAI-1antigen levels in response to training, decrements in PAI-1 antigen levels in 
response to training were more pronounced when elevated at baseline (1999). Ferguson et 
al. and Conwell et al. did not investigate changes in t-PA antigen levels in response to 
training (2008; 1999 II). Thus, it is of interest to investigate the effects of moderate-
intensity aerobic exercise training on t-PA antigen levels as its measurement may serve as 
an additional indicator of changes fibrinolytic potential in response to training (Morris et 
al., 2003). An acute bout of exhaustive exercise has been demonstrated to improve 
fibrinolytic potential in healthy male adolescents as indicated by increases in t-PA antigen 
levels and decreases in PAI-1 antigen levels (Ribeiro et al., 2007). Due to the documented 
intensity-specific responses of aerobic exercise training on fibrinolysis in adult populations 
and the potential confounding influences of diet and unsupervised training (Wang, 2006; 
Fumeron et al., 1991; Marckmann et al., 1991), it is of interest to examine the effects of 
supervised and intensity-controlled aerobic training on plasma fibrinolysis without 
substantial modifications in dietary intake.  
1.4.1 Metabolic Syndrome and Systemic Inflammation 
Studies demonstrating significant associations between metabolic syndrome 
phenotypes and body composition suggest that excessive adiposity acts as a central 
regulator in the pathological manifestations of the syndrome (Sell & Eckler, 2009; Katagiri, 
Yamada & Oka, 2007). A purported mechanism by which adipose tissue contributes to the 




inflammatory cytokines (Goldberg, 2009; Bray & Ryan, 2006; Kelly et al., 2004; Yudkin et 
al., 1999).  
CRP is a reactive acute-phase protein expressed in response to a variety of pro-
inflammatory stimuli including interleukin 1 complex (IL-1), interleukin 6 complex (IL-6), 
resistin and tumor necrosis factor α (TNF-α) (Calabrò, Golia & Yeh, 2009). CRP is 
primarily expressed in the liver and to a lesser degree in adipocytes in response to a variety 
of cytokines; its expression is, therefore, increased in obese states where excessive 
adiposity contributes to chronic low-grade systemic inflammation through the elevated 
secretion of pro-inflammatory cytokines (Yudkin et al., 2000; Tosi et al., 2009; Gabay & 
Kushner, 1999). Increased circulating levels of CRP and its pro-inflammatory stimulators 
are positively associated with body mass index, adiposity, insulin insensitivity and 
fibrinolytic impairments in both pediatric and adult populations (Balagopal et al., 2008; Qi 
et al, 2007; Nassis et al., 2005; Bastard et al., 2002; Vozarova et al., 2001). Numerous 
mechanisms linking circulating adipokines to metabolic syndrome-associated 
pathophysiology have been identified and are currently under investigation. IL-6, for 
example, has been shown to induce lipolysis which may lead to impairments in insulin 
sensitivity and fibrinolytic activity (Qi et al., 2007).  Due to the increased half life of CRP 
relative to that of its inducers, it is commonly used as a marker of chronic systemic 
inflammation (Ridker, 2003). Elevated CRP are levels are associated with an increased risk 
of developing CVD (AHA I, 2009). 
1.4.2 Exercise Training and Systemic Inflammation 
Exercise training has been documented to decrease systemic inflammation, yet the 




populations (van der Heijden et al., 2009; Balagopal et al., 2005; Kim et al. 2007; Nassis et 
al., 2005). Aerobic training has been demonstrated to decrease CRP levels in adult 
populations (Campbell et al., 2009; Obisesan et al., 2006). In youth populations, a study by 
Balagopal et al. demonstrated a ~30% decrease in CRP in 8 obese youth (BMI 38.1 ± 2.1 
kg/m
2
, age 15.6 ± 0.3 years) in response to a 12-week home-based physical activity and 
dietary education program (2005). Balagopal et al., additionally demonstrated correlations 
between decrements in fibrinogen, fasting insulin and systemic markers of inflammation in 
obese youth in response to this lifestyle intervention program (2005). However, other 
studies investigating the effects of training on systemic inflammation have not observed 
significant changes in CRP in obese youth populations (van der Heijden et al., 2009; Kim 
et al. 2007; Nassis et al., 2005). As described previously, Nassis et al. found no significant 
differences in CRP in response to 12-week game and aerobic exercise-based physical 
activity program (2005). Kim et al. did not observe changes in CRP levels in 14 obese 
(BMI 29.5 ± 2.2 kg/m
2
) Korean male adolescents (age 17 ± 0.11 years) in response to a 6-
week jump rope interval training program, despite improvements in body mass and 
composition (2007). Findings from these studies may be limited by the methodological 
approaches of the exercise programs (interval-type and lifestyle-based). 
Overall, circulating levels of CRP correlate negatively with fibrinolytic activity, 
insulin sensitivity and physical activity (Campell et al., 2009; Balagopal et al., 2008; Qi et 
al., 2007; Bastard et al., 2002). Studies examining associations between the attenuation of 
metabolic syndrome phenotypes in response to aerobic exercise training have yielded 
inconsistent findings in pediatric populations (van der Heijden et al., 2009; Balagopal et al., 




monitoring exercise intensity, and differences between training protocols and 























Chapter 2: Experimental Design and Methods 
2.1 Experimental Design 
The following describes a previously-conducted pediatric training study, conducted 
at Children‘s National Medical Center (CNMC). Collected data and stored blood samples 
were used for post-hoc investigation by the degree candidate (Ms. Many).  
  2.1.1 Subject Recruitment 
Subjects were recruited in the DC Metropolitan Area via radio and newspaper 
advertisements and locally-posted flyers. Recruitment methods specified inclusion criteria 
of obesity, age (14 to 18 years), and sedentary behavior. Subjects were incentivized to call 
through potential qualification for a free diabetes screening and enrollment in an exercise 
intervention study. Inquiring subjects underwent eligibility determination via telephone 
screening questionnaire. Subjects  reported as sedentary, BMI-for-age > 95
th
 percentile, 
nonsmoker, no known history of illness documented to affect metabolism and/or preclude 
exercise, neither pregnant nor lactating, not taking medications known to affect 
metabolism, and no known history of diabetes were invited to Screening Visit #1 for 
further eligibility determination and the consent process. 
2.1.2 Screening Visit #1 (ScV#1) 
During the consent process, protocol design, potential risks and benefits, 
compensation and participation alternatives were explained to subjects and their legal 
guarantor. All participating subjects and their guarantor gave written consent and assent as 
approved by CNMC and the National Institute of Health (NIH) Institutional Review Boards 
(IRBs). Height and weight were measured on a calibrated stadiometer and digital scale in 




administered medical history and physical activity questionnaires. A validated Modifiable 
Activity Questionnaire for Adolescents was used to assess past-year physical activity at 
baseline in order to exclude physically active individuals (ACSM, 1997). Subjects meeting 
the aforementioned inclusion criteria from ScV#1 were deemed eligible for ScV#2. 
2.1.3 Screening Visit #2 (ScV#2) 
Oral glucose tolerance testing (OGTT) was performed to screen for insulin 
resistance and undiagnosed type 2 diabetes. Subjects arrived at the CNMC GCRC after a 
12-hour overnight fast for baseline blood withdrawal. Within five minutes of venipuncture, 
1.75g/kg of glucola to a maximum of 75g was administered orally and repeat venipuncture 
was obtained 2 hours later. Urine pregnancy testing was administered on all female 
subjects as means of study exclusion. All subjects received a physical examination for 
further eligibility determination. One-hundred-and-fifty-two Black and Latino adolescents 
underwent OGTT testing and 21% (n=32) met inclusion criteria for insulin resistance as 
defined as having any of one of the following: fasting insulin > 17 µU/mL, 100mg/dL < 
fasting plasma glucose < 126 mg/dL, and/or 140 mg/dL < 2-hour OGTT plasma glucose < 
200 mg/dL. No subjects were excluded based on contradictory medical findings (illnesses 
know to affect metabolism or preclude aerobic training) upon physical examination. 
2.1.4 Dietary Monitoring Period 
Eligible subjects were given 3-day food record instructional guidelines in order to complete 
two 3-day food records each week over a two-week dietary monitoring period to establish 
baseline dietary intake. Intake was subsequently monitored by three weekly (2 weekday 




any substantive changes in dietary intake patterns. Subjects were encouraged to maintain 
current intake to control for dietary influences on outcome variables.  
2.1.5 Study Visit #1 (SV#1) 
Body composition assessment was performed using a DEXA Hologic QDR 4500A 
(Hologic, Bedford, MA). Exercise testing was performed using a modified Balke treadmill 
protocol (Rowland, 1996). Peak oxygen consumption (VO2peak) was quantified through use 
of a Medgraphics Ultima Metabolic Cart (Medical Graphics Corp., St. Paul, MN). The 
criteria for reaching VO2peak included volitional exhaustion and at least one of the 
following: 1) plateau or decrease in VO2 with increased workload; 2) RER >0.99; 3) a heart 
rate of >195 bpm (Rowland, 1996; Armstrong et al., 1994). Subjects were enrolled in the 
study if they met the aforementioned criteria and were free of cardiac pathology, as defined 
by: 1) ST elevation or depression >2mm during rest, exercise or recovery; 2) arrhythmias 
contradicting aerobic exercise; 3) ventricular tachycardia; 4) signs of poor perfusion; 5) 
history or presentation of angina pectoris; 6) hypertensive response to exercise (systolic 
blood pressure >250 mmHg and/or a diastolic blood pressure of >115 mmHg); 7) a drop in 
systolic or diastolic blood pressure with increasing work load (>10 mmHg); and/or 8) Stage 
II Clinical Hypertension (ACSM, 2000). 
2.1.6 Study Visit #2 (SV#2) 
 Subjects were admitted to the Georgetown University Medical Center (GUMC) 
GCRC after a 12-hour overnight fast, between the hours of 7 and 8 a.m. for FSIVGTT 
administration. Weight and height were measured upon arrival for glucose and insulin 
dosing. All female subjects were in the follicular stage of menstruation to control for the 




inserted in the brachial or radial artery for insulin and glucose administration. All blood 
samples were drawn from a catheter placed in the brachial or radial artery of the 
contralateral arm to prevent contamination at the injection site. After a 30-minute 
equilibration period, blood pressure, heart rate, glucose levels (by glucometer), and body 
temperature were monitored at 10-minute intervals. Fifty-percent glucose (300 mg 
glucose/kg as 50% dextrose) was administered over a 2-minute period; the initiation of 
glucose infusion was set as time zero. Blood samples for glucose and insulin measurement 
were collected at time points: –10, -1, 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 20, 22, 24, 
25, 27, 30, 40, 50, 60, 70, 80, 90, 100, 120, 160 and 180 minutes. Elapsed time was 
monitored by the study coordinator and a GUMC nurse to decrease testing errors. Humulin 
insulin (0.05 U/kg) was injected at 20-minutes to augment the insulin response. Samples 
were immediately stored on ice and centrifuged at 4C within 2 hours of being drawn for 
plasma isolation; all samples were subsequently stored at -70C until assay. During this 
visit, fasting blood samples were also obtained for the measurement of CRP and 
fibrinolytic markers. 
2.1.7 Exercise Training Period 
Our study was designed and powered from the low-volume/moderate-intensity 
STRRIDE study cohort (Houmard et al., 2004; Kraus et al., 2002). In the STRRIDE study, 
sedentary, overweight/obese individuals displaying characteristics of the metabolic 
syndrome (n=154) were randomly assigned to one of four exercise training groups: 1) low-
volume/moderate-intensity (~12 miles walking/wk at 40-55% VO2peak); 2) low-
volume/high-intensity (~12 miles jogging/wk at 65-80% VO2peak); 3) high-volume/high-




et al., 2004; Kraus et al., 2001). Dosages were achieved by training ~115 min/wk (low-
volume/high-intensity) or ~170 min/week (low-volume/moderate-intensity and high-
volume/high-intensity) with training frequencies of 3 to 4 sessions/week. Similar 
improvements in SI, ~85%, were observed in both the low-volume/moderate-intensity and 
high-volume/high-intensity training groups (Houmard et al., 2004). Due to similar 
improvements in SI in the low-volume/moderate-intensity and high-volume/high-intensity 
training groups and a greater adherence and retention rate in the low-volume/moderate-
intensity training group, we modeled our pediatric intervention study after the low-
volume/moderate-intensity STRRIDE cohort.  
Training intensity was calculated as percent peak oxygen reserve (%VO2peak R) as 
determined by treadmill testing, where VO2peak R=VO2peak – VO2rest (Wilmore, Costill & 
Kenny, 2008). Exercise prescription by this method is based upon the classic Karvonen 
method of exercise intensity prescription which uses a percentage of the physiological heart 
rate range (maximal - resting) or percent of heart rate reserve (%HRR) (Wilmore, Costill & 
Kenny, 2008). Exercise prescription based on this method accounts better accounts for 
individual variation at submaximal exercise intensities (Swain & Leutholtz, 1997). Use of 
this method is supported by a recent study which found that %HRR and %VO2peakR are 
positively correlated with observed HR and VO2 in obese individuals during treadmill 
exercise, while absolute values of %HR and %VO2peak do not display a linear relationship 
(Pinet et al., 2008).  
The observed heart rate corresponding to %VO2peakR of the desired intensity during 
treadmill testing was used for exercise prescription. All exercise sessions were monitored 




Woodbury, NY). Subjects underwent a one-month pre-training period to adjust to exercise 
and minimize musculoskeletal injury risk. During the adjustment period, a 5-10% increase 
in VO2peakR occurred each week for 4 weeks until an intensity of 45-55% VO2peak R was 
reached. Subjects exercised at target intensity 2-4 days/week for ~180 min/week in order to 
expend ~1200 kcal/week for eight consecutive weeks. Caloric expenditure was calculated 
based on the metabolic equivalent (MET) attributed to the intensity at %VO2peakR as 
measured by indirect calorimetry during baseline exercise testing. Thus, the energy cost 
was based upon body mass at baseline. 
The specified exercise dosage (1200 kcal/week) was chosen based upon 
recommendations from the Surgeon General‘s Report (CDC, 1996). Currently, the 
specified exercise dosage (~1200 kcal/week) and moderate-intensity meet ADA 
recommendations for exercise training prescription for the initial treatment of type 2 
diabetes components in previously sedentary adults (Marwick et al., 2009).  
Exercise training sessions were monitored by a trained exercise science student 
and/or exercise physiologist. Exercise modes included cycle ergometer, elliptical trainer, 
stair stepper and treadmill in order to enhance variety, adherence and retention. Body 
weight was assessed once weekly in conjunction with a questionnaire designed to assess 
medical and lifestyle changes warranting study exclusion. The protocol was designed to 
reduce potential confounding variables by excluding subjects with > 5% change in body 
mass, changes in dietary intake, initiation of exercise training outside of the study, and 






2.1.8 Study Visit #3 (SV#3) 
Upon exercise training completion, female subjects were given a urine pregnancy test no 
more than 24 hours prior to final FSIVGTT testing as a means of exclusion. FSIVGTT 
testing, as previously described (2.1.6: SV#2), was administered 24-48 hrs after the last 
bout of exercise. During this visit, fasting blood samples for CRP and fibrinolytic markers 
were also collected. 
2.1.9 Study Visit #4 (SV#4) 
Subjects were given a repeat DEXA scan and an exercise stress test to examine 
changes in body composition and cardiorespiratory fitness following exercise training. 








2.2 Experimental Methods: 
 
2.2.1 Data Collection 
Stored serum samples from the previously-described pre-existing pediatric minority study 
at Children‘s National Medical Center (CNMC); Principal Investigator: Eric Hoffman; 
CNMC Protocol #3290, were used for assay. All data were de-indentified prior to assay 
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2.2.2 Aim 1: Determination of the Effects of Aerobic Exercise 
Training on Insulin Sensitivity 
Despite the clinical utility of OGTT testing, glucose and insulin homeostasis is 
more accurately measured through frequently-sampled intravenous glucose tolerance 
testing (FSIVGTT) (Nittala et al., 2006). FSIVGTT enables quantification of the severity of 
insulin resistance through calculation of the insulin sensitivity index (SI). SI, as calculated 
by incremental glucose disappearance under the insulin curve, represents steady-state 
insulin-dependent glucose uptake (Bergman, Beard & Chen, 1986).  
           2.2.2.a     Aim 1A: Insulin and Glucose Quantification 
           Samples for insulin quantification were assayed in duplicate by use of a Mercodia 
insulin enzyme-linked immunoabsorbant assay (ELISA) (Mercodia AB, Uppsala, Sweden). 
In this procedure, insulin in the aliquoted serum sample binds to a pre-coated insulin 
antibody plate; subsequent addition of an enzyme-linked antibody binds to another insulin 
antigen. The addition of a chromogenic substrate binds to the antibody- insulin-antibody 
complex and the sample concentration of insulin is subsequently quantified by light 
absorption of bound chromogen through use of microplate reader at an absorbance of 450 
nm (Mercodia, 2008). Control samples ranging from 0 to 500 µU/ml of insulin were 
included in each assay plate to control for inter- and intra-assay testing errors. Duplicate 
samples with a coefficient of variation >15% were reran. The reliability of this assay is 
high, yielding within and between-assay coefficients of variation of 3.4 and 3.6%, 
respectively. A recent American Diabetes Association-sponsored study found that 97% of 
Mercodia insulin assays were within 15.5% of clinically manufactured insulin 




All blood samples for glucose measurement were assayed in duplicate by use of 
YSI 2300 STAT Plus glucose analyzer (YSI Inc., Yellow Springs, OH) according to the 
manufacturer‘s instructions. The reliability of the YSI 2300 is ±2% or 2.5 mg/dL per 
sample, r=0.999, for glucose concentrations between 0-900 mg/dL (YSI, 2008). Glucose 
control samples were ran daily and pre-programmed auto-calibration was performed every 
15 minutes as required by the Food and Drug Administration to control for assay validity 
and reliability (FDA, 2009). The YSI 2300 shows high concurrent validity when compared 
to samples of standardized glucose concentration, r=0.99 (FDA, 2009). 
             2.2.2.b     Aim 1B: Insulin Sensitivity Quantification  
Early insulin resistance is mostly commonly characterized by increased insulin 
production in response to peripheral and hepatic insulin insensitivity; this response 
maintains blood glucose within or only slightly above normal physiologic ranges. As 
insulin sensitivity continues to decline, the pancreatic β-cell production of insulin 
deteriorates. Eventually, the β-cells cannot produce enough insulin to regulate blood 
glucose levels, resulting in the clinically-defined onset of type 2 diabetes (Bergman, 2007; 
Shulman, 2000). The overall state of glucose and insulin homeostasis can be quantified 
through determination of insulin-stimulated glucose uptake, or insulin sensitivity (SI). Here, 













are considered impaired glucose tolerance 







(Bergman, 2007). Thus, increases in SI in response to training represent 




Insulin sensitivity was determined by FSIVGTT using the minimal model methods 
of Bergman et al. (1979). SI was calculated by use of MINMOD Millennium 
pharmacokinetic modeling software (MinMod, Inc., Pasadena, CA). Pharmacokinetic 
modeling was performed in the Department of Health of Human Performance at East 
Carolina University (ECU) by Chuck Tanner and Joseph Houmard, PhD. FSIVGTT 
analysis was performed as a collaborative effort between the degree candidate (Ms. Many), 
Dr. Houmard, and Mr. Tanner at ECU. 
MINMOD Millennium pharmacokinetic modeling software quantifies SI through 
use of a series of pre-programmed differential equations which integrate time-dependent 
plasma and injected glucose and insulin concentrations over 33 time points. This enables 
derivation of hepatic and muscular rate constants of insulin-mediated and insulin-
independent glucose uptake. Integration of these rate constants quantifies SI (Nittala et al., 
2006). FSIVGTT demonstrates strong predictive validity, where the relative risk of type 2 




 SI percentiles (Lillioja, 1993).  
Baseline and final FSIVGTT testing were performed to assess changes in SI in 
response to training. Increases in SI represent improvements in insulin sensitivity 
(Bergman, 2007). FSIVGTTs producing SI values with a fractional standard deviation 
(FSD) > 35% and/or >80% difference between peak insulin levels (at time points 20-22 
minutes, after exogenous insulin infusion) between baseline and final testing were excluded 






           2.2.2 Aim 1: Determination of the Effects of Aerobic Exercise 
Training on ‘Non-traditional’ Metabolic Syndrome Components. 
                    2.2.3.a     Aim 2A: Determination of the Effects of Aerobic Exercise 
Training on   Fibrinolytic Potential 
           Fibrinolytic activity was assessed by use of assays standardized for the clinical 
diagnosis of fibrinolytic impairments (Devin et al., 2007; Juhan-Vague et al., 1996). Assays 
for PAI-1 and t-PA activity and antigen levels are commonly used to assess for fibrinolytic 
impairments. Elevated PAI-1 antigen levels characterize impaired fibrinolysis and are 
associated with increased stroke and CVD risk (Sakkein et al., 2000; Kohler & Grant, 
2000). Reduced t-PA antigen levels also represent fibrinolytic impairments and serve as a 
clinical tool for assessing heart attack and stroke risk (Kinlay et al., 2009). Overall, 
fibrinolytic imbalances are characterized by elevated PAI-1 and decreased t-PA antigen and 
activity levels. 
Fasting plasma samples for selected fibrinolytic markers were collected between the 
hours of 7:30 and 9 a.m. in order to control for diurnal variations in fibrinolytic activity 
(Stratton et al., 1991). All samples were collected into sodium citrate tubes which protect 
against the spontaneous inactivation of t-PA and inactive PAI-1 release upon venipuncture. 
Samples were centrifuged for plasma isolation and subsequently frozen at -70°C to prevent 
platelet release of PAI-1 (Kulaputana et al., 2005).  
PAI-1 and t-PA Antigen Assays 
t-PA antigen levels were assessed by enzymatic immunoassay (TintElize, Trinity 
Biotech/Biopool). This t-PA assay is based on the double antibody principal; t-PA in the 




labeled Fab fragments bind to the t-PA antigen on the well during an incubation step. Light 
absorbance is read on a spectrometer at an absorbance of 490 nm to determine sample 
concentration by the least-squares standard curve method. The intra-assay variation for this 
assay for t-PA standards of 6 and 15 ng/mL has been documented to be 5.5 and 4.9%, 
respectively (Trinity Biotech I, 2009). The inter-assay variation for t-PA standards of 6 and 
15 ng/mL has been documented to be 3.5 and 5.4 %, respectively (Trinity Biotech I, 2009). 
The linear detection limits are between 0-30 ng/mL t-PA for undiluted samples.  
Total PAI-1 antigen was quantified by use of enzymatic immunoassay (Tintelize, 
Trinity Biotech/Biopool); this method quantifies active, inactive and complexed forms of 
circulating PAI-1 by using a double antibody principal similar to that of the aforesaid t-PA 
assay. Additionally, an adjacent well containing soluble PAI-1 conjugate antibodies served 
to rule out non-specific plate binding and, thus, protect against falsely elevated readings. 
The intra-assay variation for this assay for PAI-1 standards of 20 and 40 ng/mL has been 
documented to be 1.9 and 2.9%, respectively (Trinity Biotech II, 2009). The inter-assay 
variation for PAI-1 standards of 20 and 40 ng/mL has been documented to be 2.4 and 3.3%, 
respectively (Trinity Biotech II, 2009). The lower detection limit of PAI-1 is 0.5 ng/mL. 
Quantification of the molar ratio of PAI-1 to t-PA serves as an indicator of 
fibrinolytic balance; lower levels represent an increased capacity for fibrinolysis 
(Balagopal et al., 2008). The molar ratio of PAI-1 to t-PA was calculated by dividing 
plasma concentrations of each (ng/mL) by their respective molar weights (70,000 g/mol for 





2.2.3.b    Aim 2B: Determination of the Effects of Aerobic Exercise Training on   
CRP Levels 
All samples for quantitative CRP assay were processed at Quest Diagnostics in 
Chantilly, VA. Samples were analyzed by use of CardioPhase hsCRP reactivity kit (Dade 
Behring, Newark, DE, USA). All samples were centrifuged and aliquoted prior to 
processing to prevent sample lipemia from interfering with CRP detection. In this assay, 
polystyrene-bound monoclonal anti-CRP antibodies bind specifically to human CRP in the 
aliquoted plasma sample. The concentration of CRP is proportional to the intensity of 
scattered light as detected by immunonephelometry on a BN Nephelometer (Dade Behring, 
Newark, DE, USA). Serum controls were included in each assay to assure validity. The 
assay exhibits no cross reactivity; sensitivity of this assay is 0.175 mg/L. The intra-assay 
variation produced by this assay for samples within 0.5-15 mg/L has been documented to 
be 3.1-4.0%, respectively. The inter-assay variation for samples within 0.5-14 mg/L has 
been documented to be 2.5-2.6%, respectively (Sander et al., 2007).  
Unlike many circulating cytokines, including its primary inducers, IL-6 and TNF-α, 
CRP exhibits little diurinal variation. Due to its increased stability, a single determination 
of CRP is thought to provide an accurate assessment of CVD risk provided recorded CRP 
levels are <10 mg/L (Ridker, 2003). Measurement of CRP in large adult populations 
typically results in a rightward skewed distribution curve which is typically normalized 
upon logarithmic transformation (Rifai, Tracy & Ridker, 1999). CRP levels were thus log 
transformed prior to analysis; due to our small sample size, we were unable to validly 
assess statistical normality. Subjects presenting with CRP levels >10mg/L were excluded 




classifications were based upon the CDC/AHA standards, as follows: 1) low risk, CRP 
levels <1 mg/L; 2) moderate/average risk, CRP 1-3 mg/L; 3) high risk, >3 CRP <10 mg/L 
(AHA I, 2009). 
2.2.4   Statistics 
The chosen exercise training program was modeled after the low-
volume/moderate-intensity STRRIDE cohort which utilized a training intensity of 40-
55% VO2peak, a duration of ~170 min/week, and a frequency of 3-4 days/week (Houmard 
et al., 2004; Kraus et al., 2001).Our a priori power calculations determined the sample 
size required to detect significant changes in the initial primary protocol aim: insulin 
sensitivity. A sample size of n=11 was determined (α=0.05, β=0.80) based upon an 
observed ~85% improvement in SI in the low-volume/moderate-intensity STRRIDE 
cohort.  
Fibrin plate assays serve as an indirect indicator of total fibrinolytic capacity. An 
improvement in total fibrinolysis area, as indicated by sample euglobin clot lysis area on 
a fibrin plate, suggests underlying improvements in fibrinolytic activity (Pandolfi et al., 
2000). An increase in total clot lysis area suggests improvements in fibrinolytic activity. 
Based on an observed two-fold improvement in total fibrin lysis area, as determined by 
fibrin plate assay, of subjects enrolled in the STRRIDE study, the required sample size 
(n=11) determined to detect significant changes in SI additionally provides sufficient 
power, β=0.80, to detect an increase in fibrinolytic activity, using a significance level 
α=0.05. Here, the anticipated effect size is large, Cohen‘s d=2.84 (Hittel, Kraus & 




Previous findings from Stewart et al. demonstrate significant reductions in CRP 
levels after 12-weeks of aerobic training in physically inactive subjects aged 25 ± 5 years 
(2007). Based upon these results, a sample size of 20 yields sufficient power (β=0.80) to 
detect a significant CRP response to training, yielding a Cohen‘s d of 0.74. Despite our 
under-powered sample size (n=11), we intend to investigate changes in CRP due to a 
large anticipated effect size. Our reasoning behind expecting a greater effect size 
includes: 1) the staff-monitored and intensity-specific nature of this protocol will 
minimize modality-specific variables confounding detectable changes in CRP; 2) the high 
BMI and minority status of enrolled subjects will result in high baseline CRP levels; and 
3) a larger expected decrease in CRP levels with training is anticipated as CRP has been 
shown to decrease when initially elevated (Stewart et al., 2007). 
Data analyses were performed by use of SAS software (SAS Inst., Cary, NC). 
Comparison of baseline and final measurements was made using paired t-tests; statistical 












Chapter 3: Results 
Subjects 
Of the 32 subjects who initially qualified for study participation, 25 subjects 
completed all baseline testing visits, 15 subjects completed the entire study, and 4 of these 
15 subjects were excluded from data analysis. Three subjects were excluded from analysis 
due to abnormal dietary intake patterns and/or >5% increase in body mass, and one subject 
was excluded due to the FSIVGTT being administered >48 hours after the last bout of 
exercise. Of the 11 subjects eligible for analysis, 2 were male (1 Black/1 Latino) and 9 
were female (7 Black/2 Latina). All of these subjects were post-pubertal (Tanner growth 
stage >IV); the average age at enrollment was 15.09 ± 0.31 years. The exercise adherence 
rate was high at 87%; no subjects missed more than 3 exercise sessions. No significant 
changes in VO2peak were observed in response to training (Table 2). 
Anthropometrics 
Changes in anthropometric variables in response to training are presented in Table 
2. Subjects presented with morbid obesity at baseline as defined as a BMI >40 kg/m
2 
(Morgan et al., 2010). In response to the training program, significant reductions in body 
mass (~2 kg) and BMI (~0.8 kg/m
2
) were observed. Favorable, yet minor, changes in body 
composition including a ~3.5% reduction in both percent total body fat and percent truncal 
body fat (p<0.05), and a ~2.0% increase in lean body mass (p<0.05) were observed in 







Table 2: Changes in Selected Variables in Response to Training  
Phenotype 
  Baseline Final 
P-value n Mean ± SEM Mean ± SEM 
Body Mass and Composition 
BMI (kg/m
2
) 11 41.4 ± 1.83 40.6 ± 1.81* 0.008* 
Body mass (kg) 11 116.2 ± 7.56 114.2 ± 7.47* 0.002* 
Lean body mass (kg) 10 61.7 ± 4.05 62.9 ± 4.17* 0.032* 
Total Body Fat (%) 10 43.4 ± 1.99 41.9 ± 1.85* <0.001* 
Truncal Fat (%) 10 43.3 ± 2.01 41.7 ± 2.15* 0.043* 
Cardiorespiratory Fitness 
VO2peak (mL/kg/min) 10 22.7 ± 1.48 23.3 ± 1.84 0.437 
VO2peak (L/min) 10 2.87 ± 0.14 2.62 ± 0.21 0.127 
RER peak  10 1.13 ± 0.04 1.01 ± 0.02 0.007* 
HR peak (bpm) 9 187 ± 4 178 ± 4 0.032* 
METs peak (kcal/kg/hr) 10 6.48 ± 0.42 6.67 ± 0.52 0.435 







) 7 1.00 ± 0.15 1.37± 0.26* 0.026* 
Fasting glucose (mg/dL) 11 85.6 ± 4.46 82.1 ± 3.98 0.161 
Fasting insulin (µU/mL) 11 20.6 ± 2.86 20.2 ± 2.80 0.873 
CRP (mg/L) 10 2.53 ± 0.86 2.09 ± 0.54 0.303 
t-PA (ng/mL) 10 6.34 ± 0.51 7.32 ± 0.85 0.035* 
PAI-1 (ng/mL) 10 25.75 ± 4.46 22.79 ± 3.02 0.472 
Molar ratio of PAI-1 to t-PA 10 5.47 ± 0.79 4.46 ± 0.52 0.261 
Data are presented as means ± SEM; *p<0.05 between baseline and final paired comparisons. One 
subject was unable to complete final DEXA and treadmill testing and was thus excluded from body 
composition and ‘Cardiorespiratory Fitness’ analysis. Four subjects were excluded from SI  
analysis due to an inability to maintain venous access during FSIVGTT testing and/or FSIVGTT 
data not meeting inclusion criteria (Methods Section 2.2.2.b); all of the subjects remaining 
eligible for FSIVGTT analysis were female. One subject was excluded from CRP analysis due to 
baseline CRP levels >10 mg/L; another was excluded from t-PA and PAI-1 analysis due to 




A ~37% improvement in SI was observed in response to training (Table 2). At 
baseline, subjects presented with normal fasting glucose as defined as fasting glucose 




(Steinberger et al., 2009; Freemark & Bursey, 2001). Fasting insulin and glucose levels 
did not significantly change in response to training.  
C-Reactive Protein 
On average, subjects presented with CRP levels in the moderate risk category at 
baseline, defined as values between 1-3 mg/L by the CDC/AHA (AHA I, 2009). Three 
subjects presented with CRP levels in the CDC/AHA high risk category (>3 CRP <10 
mg/L) at baseline. CRP levels did not change significantly in response to training (Table 
2).  
Fibrinolysis 
In response to training a ~15% increase in t-PA antigen was observed. PAI-1 
antigen levels did not significantly change in response to training. A non-significant 

















Chapter 4: Discussion 
Pediatric obesity is associated with a multitude of negative health outcomes 
including type 2 diabetes, early-onset atherosclerosis, non-alcoholic fatty liver syndrome, 
sleep apnea, and polycystic ovarian syndrome (Ginsberg & MacCallum, 2009; Daniels et 
al., 2009). The rates of childhood obesity have nearly tripled in the past 30 years 
(Institute of Medicine of the National Academies, 2006). The pediatric obesity epidemic 
has caused diseases like type 2 diabetes, historically presenting in adulthood, to become 
increasingly diagnosed in youth (Kaufman, 2002). The epidemiological and economic 
impacts of pediatric obesity are projected to increase in magnitude as obese youth 
become obese adults, requiring early life-long treatment for obesity-associated 
comorbidities (Lee, 2008; Levine & Stein, 2008). Some estimates project that the 
pediatric obesity epidemic will lead to the first reduction in lifespan demonstrated in 
recent years (Olshansky et al., 2005). It is thus necessary to study the intensity-specific 
effects of aerobic training in obese pediatric groups in order to develop treatment 
guidelines as no current exercise treatment guidelines exist specifically for this high-risk 
population (Daniels et al., 2009; Marwick et al., 2009; Matyka et al., 2008).  
Pediatric minority groups display higher rates of obesity and associated 
comorbidities. Pediatric minorities additionally display higher rates of morbid obesity 
(Wang et al., 2010). Morbid obesity in youth requires aggressive treatment strategies as it 
is associated with a heightened risk of CVD, type 2 diabetes and early mortality (Wang et 
al., 2010; Lender et al., 2009). Thus, there is a critical need for studying the effects of 
intensity-specific aerobic exercise training in morbidly obese and insulin-resistant youth 




worsening of insulin sensitivity warrants more aggressive treatment methods such as 
pharmacotherapy and weight loss surgery (Lenders et al., 2009; Nadler et al., 2009; 
Daniels et al., 2009; Marwick et al., 2009; Matyka et al., 2008).  
4.1     Aim 1: The Effects of Aerobic Exercise Training on Insulin Sensitivity 
Our research findings indicate that moderate-intensity aerobic training (45-55% 
VO2peakR) performed ~180 min/week improves insulin sensitivity in morbidly obese 
adolescent minority females. These findings agree with those of previously-conducted 
training studies in pediatric populations which demonstrate improvements in insulin 
sensitivity measures (van der Heijden et al., 2009; Balagopal et al., 2008; Conwell et al., 
2008; Kim et al., 2007; Bell et al., 2007; Nassis et al., 2005). Minority groups display 
higher rates of insulin resistance, morbid obesity and different insulin dynamics relative 
to their White peers (Casazza et al., 2009; CDC, 2009; Narayan et al., 2003). Our 
findings add to this literature as this is the first study conducted in a morbidly obese 
minority cohort. Exercise training has been demonstrated to improve surrogate measures 
of insulin sensitivity (Table 1) (Balagopal et al., 2008; Nassis et al., 2005; Kim et al., 
2008; and Ferguson et al., 1999 I). However, investigating the effects of aerobic exercise 
training on direct measurements of insulin sensitivity is of interest as surrogate 
determinants do not accurately assess insulin resistance in youth populations (Brandou, 
Brun & Mercier, 2005). Our findings add to the current literature as all previous studies 
conducted in pediatric populations have utilized lifestyle-based training protocols 
(involving a combination of discontinuous aerobic and resistance exercise training) 




(van der Heijden et al., 2009; Balagopal et al., 2008; Conwell et al., 2008; Kim et al., 
2007; Bell et al., 2007; Nassis et al., 2005; Ferguson et al., 1999 I; Gutin et al., 1996). 
In minority populations, Gutin et al. did not observe significant changes in fasting 
insulin in 12 obese Black girls (age 7-11 years) after 5 weeks of mixed-modality aerobic 
training, despite a ~1.4% reduction in total body fat as determined by DEXA (1996). Our 
findings may be different than those of Gutin et al. in that training intensity was not 
standardized and heart rate was monitored only in 2 of 5 weekly training sessions. 
Additionally, Tanner growth stage was not standardized and the girls were younger than 
subjects enrolled in the present study (average age ~9 versus ~15 years). These factors 
could have confounding effects on findings from this study as insulin sensitivity tends to 
stabilize in late puberty and surrogate determinants of insulin sensitivity show limited 
validity in youth during puberty (Casazza et al., 2009; Kelly et al., 2007; Goran & 
Gower, 2001; Brandou et al., 2005). A recent study by van der Heijden et al. 
demonstrated a ~59 ± 19% improvement in peripheral insulin sensitivity as determined 
by SLFSIVGTT in obese post-pubertal Latino adolescents (age 15.6 ± 0.4 years) in 
response to 12 weeks of 120 min/week (4 x 30 min/week) of high intensity (~85% VO2 
Peak) aerobic exercise training (2009). A greater observed improvement in insulin 
sensitivity by van der Heijden et al. may be due to different FSIVGTT administration 
methods. SLFSIVGTT enables accurate quantification of both peripheral and hepatic 
insulin sensitivity; SI measurements produced by this method are typically higher and 
more precise than standard FSIVGTT testing (Avogaro et al., 1989). Thus, SI analysis by 
this method in the van der Heijden et al. study may have resulted in a greater observed 




majority of insulin-stimulated glucose uptake and training results in insulin-sensitizing 
adaptations in the skeletal muscle (Kelley, 2005; Hawley & Lessard, 2008). Subjects 
enrolled in this study were put on a 7-day low carbohydrate diet prior to SLFSIVGTT 
testing which may have resulted in greater observed improvements in insulin sensitivity 
as low carbohydrate diets prior to IVGTT testing have been shown to differentially effect 
observed changes in insulin sensitivity in response to exercise training (Cartee et al., 
1989). Our findings also extend those of van der Heijden et al. to a morbidly obese cohort 
that includes both Black and Latina adolescents. Our findings of a ~37% improvement in 
insulin sensitivity in response to moderate-intensity aerobic training (~55% VO2 peak) are 
of interest as the attainability of such high-intensity training programs may not be 
feasible in previously-sedentary and obese pediatric populations (Daniels et al., 2009).  
No significant changes in fasting insulin or fasting glucose were observed in 
response to the intervention. This is in contrast to findings from Ferguson et al. who 
demonstrated decrements in fasting insulin, but not glucose in Black, White and Asian 
children (age 7-11 years) in response to 4 months of aerobic game-based training (1999). 
Our subjects presented with hyperinsulemia at baseline (fasting insulin 20.6 ± 2.86 







fasting insulin in response to training signifies enhanced insulin sensitivity as less insulin 
is required to maintain euglycemia. Despite improvements in insulin sensitivity, our 
subjects did not normalize SI in response to training which may contribute to the 
preservation of hyperinsulemic states. Aerobic training has been documented to improve 
insulin sensitivity through a variety of intracellular mechanisms such as increased insulin 




downstream of the insulin receptor, and increased GLUT4 transcription and translocation 
(Short et al., 2003; Zierath, 2002; Shulman, 2000; Cox et al., 1999). The insulin-
sensitizing benefits of aerobic training on the skeletal muscle may be best assessed 
through quantification of insulin sensitivity rather than fasting insulin levels as changes in 
fasting insulin levels in response to training have been demonstrated to underestimate 
changes in insulin sensitivity (Schmitz et al., 2002; Short et al., 2003). Additionally, 
improvements in fasting insulin levels in response to training have been shown to 
correlate to reductions in total body fat (Short et al., 2003). Subjects enrolled in this study 
presented with extreme adiposity; despite an observed ~3.5% reduction in total body fat, 
this degree of adiposity may have additionally contributed to hyperinsulemic states after 
the intervention.  
4.2 Aim 2A: The Effects of Aerobic Exercise Training on Fibrinolytic 
Potential 
The effects of aerobic training on fibrinolysis have not been studied extensively in 
pediatric populations. Of the few studies conducted, most are limited to lifestyle-based, 
rather than intensity-specific training programs (Conwell et al., 2008; Balagopal et al., 
2008; and Ferguson et al., 1999 II). Studies in adult populations have demonstrated 
improvements in fibrinolytic activity and potential in response to training, though there is 
substantial heterogeneity and even conflicting results in the literature (Jahangard et al., 
2009; Van Guilder et al., 2005; Kulaputana et al., 2005; Hittel, Kraus & Hoffman, 2003; 
van den Burg et al., 1997; Chandler et al., 1996; Stratton et al., 1991). Different types of 




hormonal and health status of enrolled subjects, may contribute to such discrepancies in 
the literature (Kulaputana et al., 2005). 
Prior to the present study, the effects of aerobic training on fibrinolytic potential 
had not been characterized in a morbidly obese or exclusively minority pediatric 
population. Our findings demonstrate that low-volume/moderate-intensity aerobic 
training induces favorable, albeit minor, changes in fibrinolytic potential, as indicated by 
elevated t-PA antigen levels in response to training. This is in contrast to findings from 
Balagopal et al. who observed no significant changes in t-PA antigen levels in response 
to a 12-week lifestyle-based training program in obese adolescents (2008). The training 
protocol of Balagopal et al. primarily consisted of home-based exercise sessions and did 
not control for exercise intensity. The effects of aerobic training on fibrinolysis are 
largely intensity-specific (Wang, 2006). Thus, discrepant findings among studies may be 
attributable to differences in training protocols.  
t-PA is a critical regulator of fibrin clot degradation (Van Guilder et al., 2005). 
Decreased t-PA antigen levels have been associated with an increased risk of recurrent 
myocardial infarction (Gram et al., 1987). Obesity is associated with a variety of 
fibrinolytic impairments that include diminished endothelial t-PA release, which results 
in elevated thrombotic potential (Van Guilder et al., 2005). In studies in adults, aerobic 
training has been documented to increase t-PA antigen levels, enhance endothelial t-PA 
release, and increase skeletal muscle t-PA mRNA and protein expression (Jahangard et 
al., 2009; Van Guilder et al., 2005; Hittel, Kraus & Hoffman, 2003). These changes in t-
PA regulation appear to occur in conjunction with other improvements in fibrinolysis 




The effect of aerobic training on t-PA antigen levels appears to differ between 
genders. Training studies in men exhibiting improvements in fibrinolytic activity 
(enhanced t-PA and diminished PAI-1 activity) often report decrements in t-PA antigen 
levels in response to training, while women have been shown to increase t-PA antigen 
levels in response to training (Jahangard et al., 2009; Chandler et al., 1996). Differences 
in t-PA antigen levels between genders are also observed with diurnal variations in 
fibrinolytic activity, where peak t-PA antigen levels correlate with peak t-PA activity 
levels in women, but not in men (Chandler et al., 1996). Kulaputana et al. observed slight 
(~0.5 ng/mL) decrements in t-PA antigen levels in women in response to training which 
correlated with positive changes in t-PA and PAI-1 activity (2005). In the Kulaputana et 
al. study, decrements in t-PA antigen and PAI-1 activity were significantly greater in men 
versus women despite identical training protocols and similar decrements in t-PA 
activity. Despite heterogeneous findings among studies, together these data suggest that 
the mechanisms regulating fibrinolytic balance may differ between genders. Eighty-
percent of participants in our study were female which may explain the observed increase 
in t-PA antigen levels in response to training. Future studies investigating gender-
stratified training responses in fibrinolysis in obese pediatric populations are thus 
warranted. 
In contrast to our original hypothesis, no significant changes in PAI-1 antigen 
levels were observed in response to the training program. These findings agree with those 
of Conwell et al., Balagopal et al., and Ferguson et al. who found no significant changes 
in PAI-1 antigen levels in obese youth in response to lifestyle-based aerobic training 




to decrease in response to aerobic training in adult populations (Jahangard et al., 2009; 
Kulaputana et al., 2005; Hittel, Kraus & Hoffman, 2003; van den Burg et al., 1997; 
Stratton et al., 1991). Stratton et al., demonstrated improvements in fibrinolytic activity 
and potential in older (60-82 years), but not younger (24-30 years) individuals in 
response to a high-intensity aerobic training program. These findings suggest that aerobic 
training may regulate PAI-1 expression and activity differently among age groups.  
Additionally, discrepant findings between training studies in adult and youth 
populations may be due to differences in fasting insulin levels at baseline. 
Hyperinsulemia and hyperglycemia have been demonstrated to increase PAI-1 expression 
levels (Pandolfi et al., 2000; Morange et al., 1999; McGill et al., 1994). Though the 
present training program induced improvements in insulin sensitivity, subjects remained 
hyperinsulinemic after the intervention. The presence of hyperinsulemia among our 
cohort may explain differences from that of Hittel et al. and others who observed 
decrements in PAI-1 levels among subjects with normal insulinemia at baseline and in 
response to the intervention (2003). Additionally, obesity-associated inflammation is 
thought to increase PAI-1 expression levels. Our subjects presented with moderate CRP 
levels at baseline which did not significantly change in response to training. Retention of 
hyperinsulinemic and inflammatory status may have contributed to the observation of no 
significant changes in PAI-1antigen levels in response to training.  
4.3 Aim 2B: The Effects of Aerobic Exercise Training on CRP Levels 
No significant changes in CRP were observed in response to training. In pediatric 
populations, aerobic training has been documented to reduce CRP levels in response to 




(Balagopal et al., 2005). Other studies have reported no significant changes in CRP in 
response to training (van der Heijden et al., 2009; Kim et al., 2007; Nassis et al., 2005). 
None of these previously-conducted pediatric exercise training studies have investigated 
the effects of aerobic exercise training on CRP levels in morbidly obese minority youth 
populations. Nassis et al. did not observe significant changes in CRP levels in overweight 
and obese girls in response to a 12-week game-based aerobic intervention, despite 
favorable changes in insulin sensitivity as defined by total glucose and insulin area under 
the curve (2005). Kim et al. did not observe significant changes in CRP in obese Korean 
adolescent males in response to a six-week jump rope interval training program (2007). 
In contrast to these findings, Balagopal et al. demonstrated a ~30% decrement in CRP 
levels in response to a 12-week lifestyle and dietary intervention program (2005). 
Differences between studies may be due to lack of congruity between training modalities. 
Studies by Nassis et al. and Kim et al. investigated the effects of lifestyle-based and 
interval-type training protocols, respectively, and did not control for training intensity, all 
of which may limit comparisons between studies (2007; 2005). van der Heijden et al. did 
not observe significant changes in CRP levels in response to 12 weeks of high-intensity 
aerobic exercise training in obese adolescents (BMI 33.2 ± 0.9kg/m
2
, age 15.6 ± 0.4 
years), despite improvements in peripheral and hepatic insulin sensitivity as determined 
by SLFSIVGTT (2009). Additionally, our findings and others may differ from those of 
Balagopal et al. as this study included a dietary intervention component; CRP levels are 
positively correlated to dietary fat intake, thus findings from Balagopal et al., may be due 




The effects of aerobic training on CRP and other inflammatory markers are 
similarly conflicting in adult intervention studies (Church et al., 2009; Huffman et al., 
2008; Obisesan et al., 2006; Kadoglou et al., 2006). Several factors may hinder causal 
inferences made in human training studies. Despite the use of CRP levels >10 mg/L as 
means of exclusion based upon the assumption of underlying acute inflammation, 
numerous factors may affect the state of acute and chronic systemic inflammation. 
Despite the predictive utility of CRP-based CVD risk assessment, it is an acute phase 
protein. Thus, its levels may be affected by a variety of potential confounding variables 
including tobacco and environmental smoke exposure, recent dietary intake variables, sex 
hormones, sleep duration, and exposure to viruses, bacteria and environmental toxins 
(Kalogeropoulos et al., 2010; Patel et al., 2009; Wander et al., 2008; Kuo et al., 2007). 
CRP exhibits moderate with-in subject reliability (r=0.59). Thus, large-scale intervention 
studies quantifying changes in multiple inflammatory cytokines may better serve to 
investigate the effects of aerobic training on metabolic syndrome-associated systemic 
inflammation (Danesh et al., 2004).  
4.4   Study Limitations 
The major limitation of this is study is lack of a sedentary control group. A 
sedentary control group was not recruited as the risks associated with FSIVGTT testing 
were thought to outweigh participation benefits and deemed unethical by the CNMC and 
NICHD IRBs. Recruitment of a more homogenous population (i.e. stratifying for race 
and gender) may provide additional insight into gender and ethnicity-stratified training 




Findings of non-significant changes in peak oxygen consumption may be an 
additional limitation of the current study. However, the findings of significant reductions 
in RER and HR, combined with findings of no significant changes in metabolic 
equivalent units (METs) at VO2peak, suggest that ‗peak‘ exertion was lower upon retesting 
as subjects were able to exercise at nearly equivalent METs at a lower HR and RER. 
These findings suggest that changes in VO2peak cannot be validly assessed as subjects 
level of exertion was lower upon retesting.  
Many children do not give maximal exertion during peak treadmill testing and, 
thus, do not meet VO2peak testing criteria (Kang et al., 2002; Ferguson et al., 1999 I). 
Obese youth experience a high degree of peripheral fatigue during exercise, which may 
lead to premature feelings of exhaustion (Daniels et al., 2009). In unfit youth populations, 
peak oxygen consumption is usually elicited at the maximal workload obtained and does 
not typically plateau or decrease with increasing workload (Kang et al., 2002). This 
suggests that ‗VO2peak‘ testing in unfit youth is a ‗test of maximal effort‘ rather than 
maximal exercise capacity (Kang et al., 2002). However, some have suggested that 
VO2peak treadmill testing protocols are feasible, valid and accurate in obese youth 
populations, though the reliability of such testing protocols has not been established in 
morbidly obese subjects (Loftin et al., 2004; Owens & Gutin, 1999). Loftin et al. suggest 
that cycle ergometry, rather than treadmill testing, may be the optimal testing protocol for 
severely overweight youth as treadmill testing may lead to more subjective feelings of 
fatigue than cycling protocols due to greater biomechanical loading forces elicited during 
locomotion (2004). There is, thus, a need to optimize cardiorespiratory testing protocols 




testing protocols has not been established for morbidly obese and previously-sedentary 
youth. Thus, the chosen criteria for VO2peak testing (volitional exhaustion and at least one 
of the following criteria: 1) plateau or decrease in VO2 with increased workload; 2) RER 
>0.99; 3) a heart rate of >195 bpm) may have not been appropriate for our morbidly 
obese subject population. Treadmill testing protocols assessing VO2 or heart rate during a 
standardized submaximal workload may better serve to assess changes in 
cardiorespiratory fitness in morbidly obese youth as such testing is not contingent upon 
subjective feelings of exhaustion at ‗peak‘ workloads (Ferguson et al., 1999 I).    
4.5   Study Conclusions 
Examination of the effects of intensity-controlled aerobic training on obesity-
associated comorbidities is necessary to develop exercise recommendations for obese 
youth populations (Daniels et al., 2009). Inclusion of minorities in such studies is 
especially critical as the prevalence of physical inactivity, obesity and related pathologies 
are highest in minority groups (CDC, 2009). When developing exercise prescription 
guidelines for obese youth populations, training programs must be started by gradually 
increasing exercise intensity and duration in order to enhance program feasibility, 
attainability, and maintenance (Daniels et al., 2009). Our subject population represents a 
high-risk group requiring aggressive treatment methods to prevent and delay further 
obesity-associated pathologies. Investigating the effects of aerobic training on metabolic 
syndrome components is especially important as these individuals may require 
pharmacological or surgical treatment methods with continued weight gain or worsening 
of insulin sensitivity (Pratt et al., 2009; Nadler et al., 2009). Our study does not rule out 




syndrome components. However, changes in anthropometric variables were minor, 
especially when considering the subjects‘ degree of morbid obesity at baseline. 
Our study provides evidence that low-volume/moderate-intensity aerobic training 
improves insulin sensitivity and fibrinolytic potential in morbidly obese minority 
adolescents. Thus, low-volume/moderate-intensity aerobic exercise training may suffice 
as an initial treatment therapy, in combination with dietary modifications, for the 
treatment of obesity-associated comorbidities in morbidly obese and insulin-resistant 
adolescent minorities. Our findings support the use of training recommendations set forth 
by the ADA to initially treat type 2 diabetes components in previously-sedentary adults 
(ADA, 2009). Despite the observed improvements in these metabolic syndrome 
components, training programs incorporating dietary-induced weight loss in combination 
with higher training intensities and volumes may be required to attenuate other metabolic 
syndrome components, lead to greater improvements in fibrinolytic potential and insulin 
sensitivity, and further reduce the risk of obesity-associated disease. Thus, the effects of 
gradual-onset aerobic exercise training programs of higher intensities and volumes should 
be further investigated in morbidly obese youth in order to develop lifestyle treatment 
guidelines which may delay more intensive treatment alternatives such as 
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